Page last updated: 2024-11-02

oxidopamine and Uremia

oxidopamine has been researched along with Uremia in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ksiazek, A1
Solski, J1
Ali, F1
Tayeb, O1
Attallah, A1

Other Studies

2 other studies available for oxidopamine and Uremia

ArticleYear
Noradrenaline turnover in the tissues of uraemic rats.
    International urology and nephrology, 1990, Volume: 22, Issue:1

    Topics: alpha-Methyltyrosine; Animals; Catecholamines; Female; Hydroxydopamines; Kidney; Methyltyrosines; My

1990
Plasma and brain catecholamines in experimental uremia: acute and chronic studies.
    Life sciences, 1985, Nov-11, Volume: 37, Issue:19

    Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Brain; Dopamine; Epinephrine; Hydroxydopamines; K

1985